These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 26538238)

  • 1. Reactive oxygen species: players in the cardiovascular effects of testosterone.
    Tostes RC; Carneiro FS; Carvalho MH; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(1):R1-14. PubMed ID: 26538238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular Pathways of Testosterone: Clinical Implications.
    Lorigo M; Mariana M; Oliveira N; Lemos MC; Cairrao E
    J Cardiovasc Transl Res; 2020 Feb; 13(1):55-72. PubMed ID: 31820333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications.
    Lucas-Herald AK; Alves-Lopes R; Montezano AC; Ahmed SF; Touyz RM
    Clin Sci (Lond); 2017 Jul; 131(13):1405-1418. PubMed ID: 28645930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cardiovascular cellular processes by S-nitrosylation.
    Schulman IH; Hare JM
    Biochim Biophys Acta; 2012 Jun; 1820(6):752-62. PubMed ID: 21536106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative Impact of Testosterone Deficiency and 5α-Reductase Inhibitors Therapy on Metabolic and Sexual Function in Men.
    Traish AM
    Adv Exp Med Biol; 2017; 1043():473-526. PubMed ID: 29224108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation.
    Tejero J; Shiva S; Gladwin MT
    Physiol Rev; 2019 Jan; 99(1):311-379. PubMed ID: 30379623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.
    Herring MJ; Oskui PM; Hale SL; Kloner RA
    J Am Heart Assoc; 2013 Jul; 2(4):e000271. PubMed ID: 23842280
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitric oxide signalling in cardiovascular health and disease.
    Farah C; Michel LYM; Balligand JL
    Nat Rev Cardiol; 2018 May; 15(5):292-316. PubMed ID: 29388567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex hormones in the cardiovascular system.
    dos Santos RL; da Silva FB; Ribeiro RF; Stefanon I
    Horm Mol Biol Clin Investig; 2014 May; 18(2):89-103. PubMed ID: 25390005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled trials - mechanistic studies of testosterone and the cardiovascular system.
    Jones TH; Kelly DM
    Asian J Androl; 2018; 20(2):120-130. PubMed ID: 29442075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testosterone therapy and prostate cancer--safety concerns are well founded.
    Klotz L
    Nat Rev Urol; 2015 Jan; 12(1):48-54. PubMed ID: 25563848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.
    Montezano AC; Touyz RM
    Can J Cardiol; 2012 May; 28(3):288-95. PubMed ID: 22445098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance.
    Cooper SA; Whaley-Connell A; Habibi J; Wei Y; Lastra G; Manrique C; Stas S; Sowers JR
    Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2009-23. PubMed ID: 17586614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin-generated reactive oxygen species in brain and pathogenesis of cardiovascular diseases.
    Chan SH; Chan JY
    Antioxid Redox Signal; 2013 Oct; 19(10):1074-84. PubMed ID: 22429119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.
    Haddad RM; Kennedy CC; Caples SM; Tracz MJ; Boloña ER; Sideras K; Uraga MV; Erwin PJ; Montori VM
    Mayo Clin Proc; 2007 Jan; 82(1):29-39. PubMed ID: 17285783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.
    Oskui PM; French WJ; Herring MJ; Mayeda GS; Burstein S; Kloner RA
    J Am Heart Assoc; 2013 Nov; 2(6):e000272. PubMed ID: 24242682
    [No Abstract]   [Full Text] [Related]  

  • 19. Role of androgens in cardiovascular pathology.
    Chistiakov DA; Myasoedova VA; Melnichenko AA; Grechko AV; Orekhov AN
    Vasc Health Risk Manag; 2018; 14():283-290. PubMed ID: 30410343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II and oxidative stress.
    Hitomi H; Kiyomoto H; Nishiyama A
    Curr Opin Cardiol; 2007 Jul; 22(4):311-5. PubMed ID: 17556883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.